TELA BIO INC. - COMMON STOCK

TELA Bio to Participate in the JMP Securities Life Sciences Conference

02 5 2023 06:00:01 提供 Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2023 Financial Results

27 4 2023 06:00:01 提供 Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock

18 4 2023 22:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock

18 4 2023 15:01:00 提供 Nasdaq GlobeNewswire

TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023

29 3 2023 06:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

23 3 2023 06:00:01 提供 Nasdaq GlobeNewswire

TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results

21 3 2023 15:02:00 提供 Nasdaq GlobeNewswire

TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications

16 3 2023 06:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 2 2023 15:02:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques

21 2 2023 06:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization

14 2 2023 06:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

20 1 2023 15:05:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds

09 1 2023 06:00:01 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference

21 12 2022 06:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 12 2022 15:02:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference

21 11 2022 06:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2022 Financial Results

09 11 2022 15:01:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum

03 11 2022 06:00:02 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 10 2022 15:05:00 提供 Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2022 Financial Results

27 10 2022 06:00:01 提供 Nasdaq GlobeNewswire